title: Immunopathology of fatal soybean dust-induced asthma.
abstract: A hypothesis was postulated that the characteristic clinical course of fatal soybean asthma may be reflected by specific immunopathological findings. Seven cases of fatal soybean dust-induced asthma from Barcelona, Spain were compared with 25 fatal asthma cases from New Zealand. Sections of lung tissue were stained by monoclonal antibodies using standard streptavidin-biotin peroxidase technique. The following cell types were identified: mast cells, "activated" eosinophils, neutrophils, monocytes/macrophages, CD3+ T-cells and CD8+ T-cells. The positively staining cells were counted in the epithelium and the submucosa and their numbers expressed per mm and mm2, respectively. The airways were divided into larger (internal perimeter (Pi) > 2 mm) and smaller (Pi < 2 mm). Firstly, all airways were studied together; and subsequently, larger and smaller airways were studied separately. Differences in the numbers of mast cells, eosinophils, neutrophils and monocytes/macrophages between the two groups were not significant. The numbers of CD3+ and CD8+ T-cells were significantly reduced in fatal soybean asthma when all airways were taken together. In larger airways, the difference was not significant in the epithelium, but was significant in the submucosa for CD3+ cells. CD8+ cells were significantly reduced in fatal soybean asthma both in the epithelium and the submucosa. The cell counts in smaller airways were not significantly different either in the epithelium or in the submucosa for CD3+ cells. The numbers of CD8+ cells were not different in the epithelium, but were significantly reduced in the submucosa of fatal soybean asthma cases. We conclude that the numbers of CD3+ and CD8+ T-cells are substantially reduced in fatal soybean asthma. These data together with the clinical features of the fatal attack suggest a different mechanism(s) from that described for most asthma deaths, probably involving anaphylaxis.
authors.affiliation: University of Southampton, UK.
authors.forename: M
authors.initials: M
authors.lastname: Synek
authors.forename: J M
authors.initials: JM
authors.lastname: Antó
authors.forename: R
authors.initials: R
authors.lastname: Beasley
authors.forename: A J
authors.initials: AJ
authors.lastname: Frew
authors.forename: L
authors.initials: L
authors.lastname: Holloway
authors.forename: F C
authors.initials: FC
authors.lastname: Lampe
authors.forename: J L
authors.initials: JL
authors.lastname: Lloreta
authors.forename: J
authors.initials: J
authors.lastname: Sunyer
authors.forename: A
authors.initials: A
authors.lastname: Thornton
authors.forename: S T
authors.initials: ST
authors.lastname: Holgate
mesh_terms: D000328:Adult; D000368:Aged; D001249:Asthma / Q000209:etiology / Q000276:immunology* / Q000401:mortality; D001980:Bronchi / Q000276:immunology*; D017252:CD3 Complex / Q000032:analysis; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004391:Dust / Q000009:adverse effects*; D005260:Female; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D013025:Glycine max / Q000009:adverse effects*; D013030:Spain
chemical_list: D017252:CD3 Complex; D004391:Dust